Sanofi

Showing 15 posts of 579 posts found.

Genzyme image

Sanofi Gaucher drug approved in Europe

January 22, 2015
Sales and Marketing Cerdelga, Cerezyme, Gaucher, Sanofi, eliglustat, imiglucerase

The European Commission has approved Sanofi-owned Genzyme’s Cerdelga for the treatment of Gaucher disease Type 1.Designed for a condition that …

philippe_goupit_

MedDay appoints senior head from Sanofi

January 16, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philippe Goupit, Sanofi, medday

Paris-based biotech MedDay has appointed Philippe Goupit as an independent non-executive director. Goupit was until recently the vice president of …

BI image

Sanofi and Boehringer partner on biologics manufacturing

January 15, 2015
Manufacturing and Production, Sales and Marketing Boehringer, Sanofi, antibodies, biologics, cardiovascular, diabetes, mabs, manufacturing, monoclonal, oncology

Boehringer Ingelheim will help Sanofi extend its manufacturing capabilities for biologics in a new alliance, the companies have announced. Boehringer’s …

NHS drops 25 treatments from Cancer Drugs Fund

January 12, 2015
Sales and Marketing Afinitor, CDF, Cancer, Cancer Drugs Fund, Eisa, Halaven, Heribulin, Jevtana, NHS, Sanofi, Zaltrap, aflibercept, cabazitaxel, everolimus

Twenty-five cancer treatments will be removed from the Cancer Drugs Fund list, NHS England has announced. Having concluded its review …

Sanofi image

Sanofi and Regeneron post positive alirocumab results

January 9, 2015
Sales and Marketing Regeneron, Sanofi, cholesterol, heart, statin, statins

The latest trials of the potentially blockbuster new heart drug alirocumab show it lowers cholesterol in people at moderate and …

Afinitor image

Exclusive: Novartis drug struck off cancer drugs fund

January 8, 2015
Sales and Marketing Afinitor, Jevtana, NHS, NHS England, NICE, Novartis, Sanofi, everolimus

Novartis’ Afinitor (everolimus) will be removed from the Cancer Drugs Fund list when NHS England announces which drugs it can …

andrew_plump_takeda

Takeda takes senior head from Sanofi

December 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Takeda, andrew plump

Dr Andrew Plump will be joining Takeda in February from Sanofi to lead its global R&D operations as chief medical …

bernard_poussot_roche

Roche adds two to its board

December 18, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernard Poussot, Richard Lift, Roche, Sanofi

Roche intends to grow at its March annual general meeting via the election of Bernard Poussot and Richard Lift who …

Sanofi image

Sanofi looking to diversify, may buy into animal health

December 11, 2014
Manufacturing and Production, Research and Development, Sales and Marketing EFPIA, Jimenez, Sanofi, Serge Weinberg, Viehbacher, animal health

Sanofi is looking to diversify and is even considering buying into the consumer and animal health markets according to its …

Joe Jimenez image

EFPIA gives president role to Novartis chief executive

December 10, 2014
Medical Communications, Sales and Marketing EFPIA, Novartis, Sanofi, Witty, garidel, joe jimenez, oschmann

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has named Novartis chief executive Joe Jimenez as its new president. …

Sanofi image

Merck sells manufacturing facility to Sanofi

December 5, 2014
Manufacturing and Production, Sales and Marketing Merck, Merial, Puerto Rico, Sanofi, manufacturing

Sanofi’s animal health unit Merial is acquiring Merck’s manufacturing facility in Barceloneta, Puerto Rico. The proposed transaction requires the nod …

Evotec image

Evotec and Sanofi enter pre-clinical deal

December 3, 2014
Research and Development, Sales and Marketing DiaPep277, Evotec, Sanofi, oncology, priftin, toulouse

Evotec and Sanofi have entered negotiations for a major multi-component strategic alliance worth around €250 million over the next five …

FDA image

FDA clears Sanofi TB drug indication

December 2, 2014
Research and Development, Sales and Marketing Bedaquiline, FDA, Sanofi, WHO, priftin, rifapentine, sirturo

The FDA has approved Sanofi’s Priftin for a new tuberculosis (TB) indication following a priority review from the regulator. Priftin …

BI image

CHMP nods several drugs through

November 24, 2014
Sales and Marketing Boehringer, CHMP, EMA, Esbriet, FDA, Sanofi, nintedanib, ofev

Ten new medicines have been recommended for approval by the EMA’s Committee for Medicinal Products for Human Use (CHMP), among …

Sanofi image

Sanofi showcases alirocumab at AHA

November 20, 2014
Sales and Marketing Amgen, PCSK9, Regeneron, Sanofi, aha, alirocumab, evolocumab

Sanofi and Regeneron released a battery of new Phase III data on their PCSK9 inhibitor alirocumab this week, reinforcing the …

The Gateway to Local Adoption Series

Latest content